SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Traders are focused on LUNRs reported selection for NASAs CLPS 2.0 program and the dismissal of a bid protest, speculating that the awards could add to its backlog. The sharp rebound has fueled bullish and short-squeeze talk, while skeptics question the contract value and whether the rally will hold.

American Express Co. engages in the provision of card-issuing, merchant-acquiring, and card network businesses. Its products and services include credit cards, business credit cards, corporate programs, gift cards, savings accounts and CDs, and the American Express App. It operates through the following segments: the United States Consumer Services (USCS), Commercial Services (CS), International Card Services (ICS), Global Merchant and Network Services (GMNS), and Corporate and Other. The USCS segment includes proprietary consumer cards and provides services to United States consumers. The CS segment offers corporate and small business cards and provides services to United States businesses. The ICS segment provides consumers, small businesses, and corporate cards outside the United States. The GMNS segment is involved in operating a global payments network that processes and settles card transactions, acquires merchants, and provides multi-channel marketing programs and capabilities, services and data analytics. The Corporate and Other segment covers corporate functions and certain other businesses and operations. It also operates through the following geographical segments: United States, EMEA, APAC, LACC, and Other. The EMEA segment represents Europe, the Middle East, and Africa. The APAC segment refers to Asia Pacific, Australia, and New Zealand. The LACC segment focuses on Latin America, Canada, and the Caribbean. The Other segment includes net costs which are not directly allocated to specific geographic regions. The company was founded by Henry Wells, William G. Fargo, and John Warren Butterfield on March 28, 1850 and is headquartered in New York, NY.

American Express Co.

American Express shares are drawing attention after earnings beat expectations and management raised its outlook, but the stock fell amid plans to cut about 5% of its workforce as part of an AI-focused restructuring. Traders are split between viewing the selloff as an overreaction given resilient card spending and worrying about the job cuts, consumer strength, and softer revenue growth.

ARK ETF Trust - ARK Innovation ETF

ARK Innovation ETF

Cathie Woods active portfolio rotations are fueling debate around ARKK: critics point to its long-term underperformance and volatile growth-stock exposure, while bulls see signs of a technical recovery and renewed momentum.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshires Q3 results drew attention as operating earnings declined on weaker insurance underwriting, while share repurchases surged to a quarterly record. Traders are divided between concern about the earnings softness and viewing the buybacks as a sign of management confidence in Berkshires value.

Voyager Technologies, Inc. engages in the defense technology and space solutions. It operates through the following segments: Defense and Space Technologies, and Starlab Space Stations. The Defense and Space Technologies segment consists of innovative mission-critical solutions to protect dynamic and contested domains. The Starlab Space Stations segment consists of a commercial space station. The company was founded by Dylan Taylor and Matthew Kuta on August 15, 2019 and is headquartered in Denver, CO.

Voyager Technologies Inc. - Ordinary Shares - Class A

Voyagers strong quarterly update, raised full-year outlook and NASA contract are driving attention alongside the sharp share-price move. Bulls welcome the growth and contract momentum, while skeptics point to weak margins, cash needs and past underperformance as reasons for caution.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimunes FDA approval of TUDRIQEV has shifted attention to its U.S. launch and early physician uptake, amid a sharp rally and heavy call-option interest. Bulls point to launch momentum and a possible short squeeze, while skeptics question whether commercial demand can justify the valuation and ease cash-burn concerns.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai is drawing attention after Northland upgraded the stock, citing C3 Code as a potential growth driver for building agentic AI applications; traders are debating whether the resulting move can hold. Bullish talk about call activity and short-squeeze potential contrasts with skepticism over the companys declining revenue and ability to turn AI demand into growth.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AIs quarterly results topped expectations and the company raised its full-year revenue outlook, driving a rally and renewed bullish talk about growth in diagnostics and data services. Traders are watching whether the earnings momentum can persist, while others point to sharp post-report swings and lingering concerns about valuation and hospital adoption.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco is drawing attention ahead of its quarterly report after a sharp pullback, with traders looking for guidance on AI-related networking demand and margins. The debate is whether data-center spending will sustain orders or whether project delays and tighter budgets will weaken demand; some see the selloff as overdone, while others remain wary after the analyst downgrade and recent weakness.

Redwire Corp. engages in the development and provision of space and defense technologies and mission-critical solutions for government, commercial, and civil customers. Its offerings include spacecraft platforms, space infrastructure, avionics, sensors and payloads, power generation systems, radio frequency systems, microgravity research and manufacturing technologies, autonomous systems, optical sensors, and digital engineering solutions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwires quarterly results are driving attention: revenue came in below expectations, while gross margins and backlog reached records and full-year guidance was reaffirmed. Traders are split between concern about converting backlog into revenue and optimism that improving margins and new defense-space awards support the longer-term outlook; the shares have swung sharply around the report.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Healthcare ETFs to Buy as JNJ Slips 6% Despite Q3 Earnings Beat 

Johnson & Johnson's Q3 earnings beat fails to prevent a 6% stock drop, but three healthcare ETFs offer diversified exposure to its growth potential. 

Execution of Pharma Tariffs Brings These ETFs Into Focus

Trump's 100% pharma tariff is reshaping the drug industry. Here's how the key pharma ETFs could be affected.

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

Healthcare ETFs Are Looking Up: Here's Why 

Healthcare ETFs are hitting 52-week highs as earnings improve, dealmaking accelerates, FDA approvals stay strong and investors seek defensive growth.

PFE, MRK, SNY, MRNA In Focus As Trump Reportedly Eyes Executive Order On Vaccines And Autism

Equity

The order’s contents remain unclear, and timing could shift, Bloomberg reported, citing people familiar with the matter.


Will Generic Drug Tariffs Impact Pharma ETFs?

New U.S. tariffs on generic drugs could pressure drugmakers and influence pharmaceutical ETFs. Here's what investors should watch.

ETFs to Buy Post JNJ's Q2 Earnings Beat & Bullish 2026 Outlook

 Johnson & Johnson's Q2 beat and strong pharma momentum are raising interest in healthcare ETFs with sizable exposure to the company.

Healthcare ETFs to Buy as JNJ Beats the Market With a 25% YTD Surge

JNJ's 25% year-to-date surge and recent FDA approval fuel interest in healthcare ETFs with diversified sector exposure. 

Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market

GLP-1 drugs are reshaping healthcare and consumer markets. These ETFs offer targeted exposure to the booming obesity-drug trend.

iShares Trust - iShares U.S. Pharmaceuticals ETF

Bullish Sentiment

<ul class="summary-bullets"><li>Decades of rigorous scientific research have consistently found no causal connection between childhood vaccines and autism.</li><li>However, Robert F. Kennedy Jr., now Health and Human Services secretary, has been a central figure in the modern anti-vaccine movement for two decades.</li><li>In May, the administration ordered the Centers for Disease Control and Prevention and its vaccine advisory panel to review U.S. childhood vaccine recommendations and consider aligning them with other developed countries that use fewer routine shots.</li></ul>The Donald Trump administration is reportedly actively considering an executive order on vaccines and autism, with a possible move as early as the week ahead. &nbsp;The order’s contents remain unclear, and timing could shift, Bloomberg <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2026-08-06/trump-administration-considers-order-on-autism-and-vaccines">reported</a>, citing people familiar with the matter. According to the news platform’s sources, the options under discussion by officials include research efforts that cover both prospective studies and reviews of historical data.Any order casting doubt on vaccines or further curtailing recommendations could pressure shares of major manufacturers reliant on childhood and routine immunization revenue. Key names include Pfizer (PFE), Moderna (MRNA), BioNTech (BNTX), GSK (GSK), Sanofi (SNY), and Merck (MRK).While PFE, MRK, and SNY shares traded marginally lower after-hours at the time of writing, MRNA edged up 1.5%, likely due to the <a href="https://stocktwits.com/news-articles/markets/equity/mrna-stock-pares-gains-despite-fda-green-light-for-first-m-rna-flu-vaccine-but-retail-cheers-pivot-beyond-covid/cZoB5gXRJJQ">recent approval</a> of its flu vaccine on Wednesday.<h2 class="st-heading-2">The War Against Vaccines</h2>Decades of rigorous scientific research have consistently found no causal connection between childhood vaccines and autism.Robert F. Kennedy Jr., who serves as Health and Human Services secretary, has long been a leading voice in the modern anti-vaccine movement through his earlier leadership of Children’s Health Defense. In the current administration, he has overhauled a federal autism advisory panel by appointing members affiliated with organizations that advance unproven claims of vaccine-autism links, ordered research aimed at exploring such connections, and backed efforts to scale back the recommended childhood immunization schedule. &nbsp;President Donald Trump has voiced skepticism about vaccines for more than a decade, including assertions dating to the 2016 campaign and earlier that childhood immunizations contribute to autism. He has also repeated unsupported associations involving vaccines, acetaminophen use during pregnancy, and climbing autism diagnosis rates, while advising parents to space or postpone certain shots—even as he has stated that he remains in favor of vaccines overall. &nbsp;In May 2026, the administration issued an executive order directing the Centers for Disease Control and Prevention and its advisory committee to review an HHS assessment and realign the U.S. childhood vaccine schedule with practices in peer-developed countries that recommend fewer routine shots; earlier related moves faced court challenges.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around iShares U.S. Pharmaceuticals ETF, which holds major multinational vaccine producers alongside general drug manufacturers, rose from ‘bearish’ to ‘bullish’ over the past 24 hours, while retail chatter stayed at ‘low’ levels.<a href="https://stocktwits.com/symbol/IHE">IHE</a> has gained 21% year-to-date.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/dkng-stock-slips-after-hours-as-q2-earnings-disappoint-ceo-says-predictions-growing-faster-than-expected-ready-to-win-nfl-season/cZoBQgERJJs">DKNG Stock Slips After-Hours As Q2 Earnings Disappoint — CEO Says Predictions Growing Faster Than Expected, Ready To Win NFL Season</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

U.S. President Donald Trump speaks during a bilateral meeting at the Bestepe Presidential Compound, following Trump’s arrival to attend the annual NATO Summit on July 7, 2026 in Ankara, Turkey. (Photo by Win McNamee/Getty Images)

Decades of rigorous scientific research have consistently found no causal connection between childhood vaccines and autism.However, Robert F. Kennedy Jr., now Health and Human Services secretary, has been a central figure in the modern anti-vaccine moveme

Glaxosmithkline plc - ADR

iShares U.S. Pharmaceuticals ETF

Merck & Co Inc

Moderna Inc

Pfizer Inc

Sanofi-Aventis

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

IHE iShares U.S. Pharmaceuticals ETF

Fundamentals

Latest IHE News